{"id":472485,"date":"2021-04-07T07:03:28","date_gmt":"2021-04-07T11:03:28","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=472485"},"modified":"2021-04-07T07:03:28","modified_gmt":"2021-04-07T11:03:28","slug":"evogene-to-hold-virtual-investor-analyst-days","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/","title":{"rendered":"Evogene to Hold Virtual Investor &amp; Analyst Days"},"content":{"rendered":"<div class=\"xn-newslines\">\n<h2 class=\"xn-hedline\">Hebrew language event on Monday, April 19, 2021<\/h2>\n<h2 class=\"xn-hedline\">English language event on Wednesday, April 21, 2021<\/h2>\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>REHOVOT, <span class=\"xn-location\">Israel<\/span>, <span class=\"xn-chron\">April 7, 2021<\/span> \/PRNewswire\/ &#8212; Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN),\u00a0a leading computational biology company today announced that it will hold virtual investor and analyst days, in both Hebrew and English, via Zoom webinars.<\/p>\n<div id=\"prni_dvprnejpgd73cleft\" dir=\"ltr\">\n        <img decoding=\"async\" id=\"prnejpgd73cleft\" title=\"Evogene Logo\" border=\"0\" alt=\"Evogene Logo\" align=\"middle\" src=\"https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg\" \/>\n      <\/div>\n<p>The meetings will feature key-note presentations from Evogene&#8217;s CEO, <span class=\"xn-person\">Ofer Haviv<\/span>, and the CEOs of Evogene group subsidiaries Biomica, Canonic, AgPlenus, and <span class=\"xn-person\">Lavie Bio<\/span>, followed by a question and answer session. <\/p>\n<ul type=\"disc\">\n<li>The Hebrew language event will be held on <span class=\"xn-chron\">Monday, April 19, 2021<\/span> at <span class=\"xn-chron\">4pm IST<\/span> or <span class=\"xn-chron\">9am ET<\/span>. To register for this event, please visit the link:<br \/><a target=\"_blank\" href=\"https:\/\/zoom.us\/webinar\/register\/WN_MpdKOdKeTvqyR6LDbpJlCQ\" rel=\"nofollow noopener noreferrer\">https:\/\/zoom.us\/webinar\/register\/WN_MpdKOdKeTvqyR6LDbpJlCQ<\/a>\u00a0 <\/li>\n<li>The English language event will be held on <span class=\"xn-chron\">Wednesday, April 21, 2021<\/span> at <span class=\"xn-chron\">4pm IST<\/span> or <span class=\"xn-chron\">9am ET<\/span>. To register for this event, please visit the link:<br \/><a target=\"_blank\" href=\"https:\/\/zoom.us\/webinar\/register\/WN_k8B2V0g_R9e1xYv5WIpt6A\" rel=\"nofollow noopener noreferrer\">https:\/\/zoom.us\/webinar\/register\/WN_k8B2V0g_R9e1xYv5WIpt6A<\/a>\u00a0<\/li>\n<\/ul>\n<p>\u00a0<\/p>\n<p>Questions to the speakers may be sent in advance of the event via the registration link or to <a target=\"_blank\" href=\"mailto:ir@evogene.com\" rel=\"nofollow noopener noreferrer\">ir@evogene.com<\/a>\u00a0or may be sent via the Question and Answer link in the zoom webinar during the event.<\/p>\n<p>\n        <b>About Evogene Ltd.:<\/b>\n      <\/p>\n<p>Evogene (NASDAQ: EVGN), (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform.\u00a0 The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements.\u00a0 Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ltd. <\/p>\n<p>\u00a0<\/p>\n<div>\n<table id=\"convertedTablecef8\" cellspacing=\"0\" cellpadding=\"0\" border=\"1\" class=\"prntblns\">\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Evogene Investor Contact<\/b><br \/>\n                  <b>: <\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>US Investor Relations:<\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n              \n            <\/td>\n<td class=\"prngen2\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Rivka Neufeld \/ Aviva Banczewski\u00a0<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Joseph Green<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Investor Relations <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Edison Group<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">E: <a target=\"_blank\" href=\"mailto:IR@evogene.com\" class=\"prnews_a\" rel=\"nofollow noopener noreferrer\">IR@evogene.com<\/a><\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">E: <a target=\"_blank\" href=\"mailto:jgreen@edisongroup.com\" class=\"prnews_a\" rel=\"nofollow noopener noreferrer\">jgreen@edisongroup.com<\/a><\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">T: +972-8-931-1900<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">T: +1 646-653-7030<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen3\">\n              \n            <\/td>\n<td class=\"prngen3\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen3\">\n              \n            <\/td>\n<td class=\"prngen3\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen3\">\n              \n            <\/td>\n<td class=\"prngen3\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen3\">\n              \n            <\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Laine Yonker<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen3\">\n              \n            <\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Edison Group<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen3\">\n              \n            <\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">E: <a target=\"_blank\" href=\"mailto:lyonker@edisongroup.com\" class=\"prnews_a\" rel=\"nofollow noopener noreferrer\">lyonker@edisongroup.com<\/a><\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen3\">\n              \n            <\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">T: +1 646-653-7035<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN34751&amp;sd=2021-04-07\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/evogene-to-hold-virtual-investor--analyst-days-301263905.html\">http:\/\/www.prnewswire.com\/news-releases\/evogene-to-hold-virtual-investor&#8211;analyst-days-301263905.html<\/a><\/p>\n<p>SOURCE  Evogene<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LN34751&amp;Transmission_Id=202104070700PR_NEWS_USPR_____LN34751&amp;DateId=20210407\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hebrew language event on Monday, April 19, 2021 English language event on Wednesday, April 21, 2021 PR Newswire REHOVOT, Israel, April 7, 2021 \/PRNewswire\/ &#8212; Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN),\u00a0a leading computational biology company today announced that it will hold virtual investor and analyst days, in both Hebrew and English, via Zoom webinars. The meetings will feature key-note presentations from Evogene&#8217;s CEO, Ofer Haviv, and the CEOs of Evogene group subsidiaries Biomica, Canonic, AgPlenus, and Lavie Bio, followed by a question and answer session. The Hebrew language event will be held on Monday, April 19, 2021 at 4pm IST or 9am ET. To register for this event, please visit the link:https:\/\/zoom.us\/webinar\/register\/WN_MpdKOdKeTvqyR6LDbpJlCQ\u00a0 The English language event will be held on &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Evogene to Hold Virtual Investor &amp; Analyst Days&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-472485","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Evogene to Hold Virtual Investor &amp; Analyst Days - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evogene to Hold Virtual Investor &amp; Analyst Days - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Hebrew language event on Monday, April 19, 2021 English language event on Wednesday, April 21, 2021 PR Newswire REHOVOT, Israel, April 7, 2021 \/PRNewswire\/ &#8212; Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN),\u00a0a leading computational biology company today announced that it will hold virtual investor and analyst days, in both Hebrew and English, via Zoom webinars. The meetings will feature key-note presentations from Evogene&#8217;s CEO, Ofer Haviv, and the CEOs of Evogene group subsidiaries Biomica, Canonic, AgPlenus, and Lavie Bio, followed by a question and answer session. The Hebrew language event will be held on Monday, April 19, 2021 at 4pm IST or 9am ET. To register for this event, please visit the link:https:\/\/zoom.us\/webinar\/register\/WN_MpdKOdKeTvqyR6LDbpJlCQ\u00a0 The English language event will be held on &hellip; Continue reading &quot;Evogene to Hold Virtual Investor &amp; Analyst Days&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-07T11:03:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-hold-virtual-investor-analyst-days\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-hold-virtual-investor-analyst-days\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Evogene to Hold Virtual Investor &amp; Analyst Days\",\"datePublished\":\"2021-04-07T11:03:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-hold-virtual-investor-analyst-days\\\/\"},\"wordCount\":380,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-hold-virtual-investor-analyst-days\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/890385\\\/Evogene_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-hold-virtual-investor-analyst-days\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-hold-virtual-investor-analyst-days\\\/\",\"name\":\"Evogene to Hold Virtual Investor &amp; Analyst Days - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-hold-virtual-investor-analyst-days\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-hold-virtual-investor-analyst-days\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/890385\\\/Evogene_Logo.jpg\",\"datePublished\":\"2021-04-07T11:03:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-hold-virtual-investor-analyst-days\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-hold-virtual-investor-analyst-days\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-hold-virtual-investor-analyst-days\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/890385\\\/Evogene_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/890385\\\/Evogene_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-hold-virtual-investor-analyst-days\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evogene to Hold Virtual Investor &amp; Analyst Days\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evogene to Hold Virtual Investor &amp; Analyst Days - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/","og_locale":"en_US","og_type":"article","og_title":"Evogene to Hold Virtual Investor &amp; Analyst Days - Market Newsdesk","og_description":"Hebrew language event on Monday, April 19, 2021 English language event on Wednesday, April 21, 2021 PR Newswire REHOVOT, Israel, April 7, 2021 \/PRNewswire\/ &#8212; Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN),\u00a0a leading computational biology company today announced that it will hold virtual investor and analyst days, in both Hebrew and English, via Zoom webinars. The meetings will feature key-note presentations from Evogene&#8217;s CEO, Ofer Haviv, and the CEOs of Evogene group subsidiaries Biomica, Canonic, AgPlenus, and Lavie Bio, followed by a question and answer session. The Hebrew language event will be held on Monday, April 19, 2021 at 4pm IST or 9am ET. To register for this event, please visit the link:https:\/\/zoom.us\/webinar\/register\/WN_MpdKOdKeTvqyR6LDbpJlCQ\u00a0 The English language event will be held on &hellip; Continue reading \"Evogene to Hold Virtual Investor &amp; Analyst Days\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-07T11:03:28+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Evogene to Hold Virtual Investor &amp; Analyst Days","datePublished":"2021-04-07T11:03:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/"},"wordCount":380,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/","name":"Evogene to Hold Virtual Investor &amp; Analyst Days - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg","datePublished":"2021-04-07T11:03:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-hold-virtual-investor-analyst-days\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Evogene to Hold Virtual Investor &amp; Analyst Days"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/472485","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=472485"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/472485\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=472485"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=472485"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=472485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}